💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC 🎯mOS: 25.6 vs 12.3m | HR 0.49 🎯mPFS: 9.7 vs 6.9m | HR 0.56 🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m For LA ESCC, tislelizumab adds reason to the rationale. 🔍 #OncoAlert @OncoAlert

MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert

Clinical research co-led by BGI-Research demonstrated the safety and feasibility of a neoadjuvant immunotherapy anti-PD-L1 medication #Adebrelimab for patients with locally advanced esophageal squamous cell carcinoma. bit.ly/3rIHrHe #EsophagealCancer #ESCC

TheBgiGroup's tweet image. Clinical research co-led by BGI-Research demonstrated the safety and feasibility of a neoadjuvant immunotherapy anti-PD-L1 medication #Adebrelimab for patients with locally advanced esophageal squamous cell carcinoma. bit.ly/3rIHrHe #EsophagealCancer #ESCC

Excited to share our Ph2 PALADIN trial poster! #GI26 @ASCO @OncoAlert #Pembrolizumab #ESCC

DaisukeKotani's tweet image. Excited to share our Ph2 PALADIN trial poster! #GI26 

@ASCO @OncoAlert  #Pembrolizumab #ESCC

ASCO-GI 2026, abstr TPS471 🔷PALADIN: Ph2 of pembro + chemo with SCRT (25Gy/5fr) as induction tx for unresectable LA-ESCC 👉Please check out our ongoing trial exploring ICI + hypofractionated RT strategy! #GI26 @ASCO @OncoAlert



Toripalimab Plus Chemo Wins European Approval for Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma. @EU_Commission @sysu_1924 #oncology #ESCC onclive.com/view/toripalim…


🚧 ESCC Highways are out tonight removing flags painted on mini roundabouts in the Newhaven area. ❓ But how long until the next ones appear – and is this really money well spent by the council? #Newhaven #SussexNews #ESCC @SussexTW

SussexIncidents's tweet image. 🚧 ESCC Highways are out tonight removing flags painted on mini roundabouts in the Newhaven area.

❓ But how long until the next ones appear – and is this really money well spent by the council?

#Newhaven #SussexNews #ESCC

@SussexTW

A new molecular framework for #ESCC is here. In Signal Transduction and Targeted Therapy (Nature), investigators define consensus molecular subtypes of esophageal squamous cell carcinoma, integrating multi-omics data to refine biological classification and therapeutic


🏀 #ESCC #GAMEDAY🏀 @ViatorGBB vs. Nazareth Academy 🏟️ Saint Viator HS 📍1213 E Oakton St, Arlington Hts 60004 📺 fan.hudl.com/usa/il/arlingt… #GoLions

ViatorGBB's tweet image. 🏀 #ESCC #GAMEDAY🏀

@ViatorGBB vs. Nazareth Academy

🏟️ Saint Viator HS
📍1213 E Oakton St, Arlington Hts 60004
📺 fan.hudl.com/usa/il/arlingt…

#GoLions

Frontline tislelizumab combined with chemotherapy in RATIONALE-306 showed substantial and clinically meaningful improvements in OS for advanced or metastatic esophageal squamous cell carcinoma. #ESCC #ESMOGI2025 Read more here: hubs.li/Q03zykZF0


🧭 @INTOverse_ cemented a partnership with @ESCC_io 🧭 #ESCC redefines the stablecoin landscape by merging the high-performance architecture of @EOSIO with the adaptability of #EOS EVM 🔽 VISIT escc.io #SCN1

SmartCryptoNew1's tweet image. 🧭 @INTOverse_ cemented a partnership with @ESCC_io

🧭 #ESCC redefines the stablecoin landscape by merging the high-performance architecture of @EOSIO with the adaptability of  #EOS EVM

🔽 VISIT
escc.io
#SCN1

🎙️Join us for the BinanceLiveAMA series with #ESCC 🕰️ Date: 19th Dec 2024, 8 PM UTC+8 🏆 Prize: $100 USD 🏠 Venue: binance.com/en/live/u/2747… 〽️Rules: 1️⃣ Follow @Cryptowhale1988 & @ESCC_io 2️⃣ Like & RT 3️⃣ Comment your Questions (Max 3) 4️⃣ Tag 3 Friends

CryptoWhale1988's tweet image. 🎙️Join us for the BinanceLiveAMA series with #ESCC

🕰️ Date: 19th Dec 2024, 8 PM UTC+8
🏆 Prize: $100 USD 
🏠 Venue: binance.com/en/live/u/2747…

〽️Rules:
1️⃣ Follow @Cryptowhale1988 & @ESCC_io
2️⃣ Like & RT
3️⃣ Comment your Questions (Max 3)
4️⃣ Tag 3 Friends

Consensus Molecular Subtypes of #ESCC ✅Key previous classifications ◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017) ◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023) ✅This study integrates 8 prior systems to establish 4 consensus subtypes ◾️ECMS1-MET (metabolic): Dysregulated

DaisukeKotani's tweet image. Consensus Molecular Subtypes of #ESCC
✅Key previous classifications
◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017)
◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023)

✅This study integrates 8 prior systems to establish 4 consensus subtypes
◾️ECMS1-MET (metabolic): Dysregulated
DaisukeKotani's tweet image. Consensus Molecular Subtypes of #ESCC
✅Key previous classifications
◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017)
◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023)

✅This study integrates 8 prior systems to establish 4 consensus subtypes
◾️ECMS1-MET (metabolic): Dysregulated

A post-hoc analysis of the RATIONALE-306 trial confirms that adding tislelizumab to chemotherapy significantly improves efficacy for patients with locally advanced esophageal squamous cell carcinoma. #ESCC Read more here: hubs.li/Q03zyjv20

OncLive's tweet image. A post-hoc analysis of the RATIONALE-306 trial confirms that adding tislelizumab to chemotherapy significantly improves efficacy for patients with locally advanced esophageal squamous cell carcinoma. #ESCC 
Read more here:
hubs.li/Q03zyjv20

Presentation Evening News! 🏆 Date: Saturday 11th October Time: 7pm-12am Venue: St Neots football club. Tickets: £15 pp Awards, Food & Music 🍻🍽️🎵 Players, families, friends & sponsors all welcome! Please get in touch if you’d like to attend #ESCC

EatonSoconcc's tweet image. Presentation Evening News! 🏆 

Date: Saturday 11th October 
Time: 7pm-12am 
Venue: St Neots football club. 
Tickets: £15 pp
Awards, Food & Music 🍻🍽️🎵 
Players, families, friends & sponsors all welcome! Please get in touch if you’d like to attend 

#ESCC

Ian Chau, MD (@royalmarsden) discusses SKYSCRAPER-07 in unresectable ESCC post-CRT. 💉 Atezolizumab ± tiragolumab 📊 Dual blockade = no added OS/PFS benefit 💪 Atezolizumab alone: 31% ↓ risk of death 🎥 ow.ly/oE1J50Xl3jx #ESCC #ImmunoOnc #ESMO25 This video is available


🌅 @ESCC_io partners with @MetaOceanPark, the solution provider for Web3 game traffic and inscription assets. 🌅 #ESCC is a pioneering blockchain platform, intricately designed to optimize and facilitate transactions involving stablecoins. 🔽VISIT escc.io

Digital_Diary1's tweet image. 🌅 @ESCC_io partners with @MetaOceanPark, the solution provider for Web3 game traffic and inscription assets.

🌅 #ESCC is a pioneering blockchain platform, intricately designed to optimize and facilitate transactions involving stablecoins. 

🔽VISIT
escc.io

Corrida disputadíssima na ESCC! Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida! #ESCC #GoBravoSnow

BravoSnowBR's tweet image. Corrida disputadíssima na ESCC!

Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida!

#ESCC #GoBravoSnow
BravoSnowBR's tweet image. Corrida disputadíssima na ESCC!

Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida!

#ESCC #GoBravoSnow

#ESCC #GoLions Bella Gounaris 14 pts, 2 rebs, 2 stls Ava Garcia 8 pts, 4 rebs, 5 stls, 3 assts Kalin McCrea 7 pts, 4 rebs, 2 stls, 2 assts

ViatorGBB's tweet image. #ESCC #GoLions

Bella Gounaris 14 pts, 2 rebs, 2 stls
Ava Garcia 8 pts, 4 rebs, 5 stls, 3 assts
Kalin McCrea 7 pts, 4 rebs, 2 stls, 2 assts

ESCC goes out on top in girls and boys 🏀 4A. What a run…#ESCC

Marist will play Benet, a 39-38 winner over DePaul Prep in the second semi. Fitting ending for the ESCC, which is merging with the Catholic League next school year.



@STTTJournal: an AI classifier using routine H&E pathology slides—no expensive sequencing needed. This enables precision subtyping & personalized treatment at lower cost, bringing real clinical utility to ESCC care.Primary: #ESCC #PrecisionMedicine #AI #Pathology

Oncologynewspro's tweet image. @STTTJournal: an AI classifier using routine H&E pathology slides—no expensive sequencing needed. 
This enables precision subtyping & personalized treatment at lower cost, bringing real clinical utility to ESCC care.Primary: 
#ESCC #PrecisionMedicine #AI #Pathology
Oncologynewspro's tweet image. @STTTJournal: an AI classifier using routine H&E pathology slides—no expensive sequencing needed. 
This enables precision subtyping & personalized treatment at lower cost, bringing real clinical utility to ESCC care.Primary: 
#ESCC #PrecisionMedicine #AI #Pathology
Oncologynewspro's tweet image. @STTTJournal: an AI classifier using routine H&E pathology slides—no expensive sequencing needed. 
This enables precision subtyping & personalized treatment at lower cost, bringing real clinical utility to ESCC care.Primary: 
#ESCC #PrecisionMedicine #AI #Pathology
Oncologynewspro's tweet image. @STTTJournal: an AI classifier using routine H&E pathology slides—no expensive sequencing needed. 
This enables precision subtyping & personalized treatment at lower cost, bringing real clinical utility to ESCC care.Primary: 
#ESCC #PrecisionMedicine #AI #Pathology

Easter Family Fun Day 🐣 Our Easter Family Fun Day is fast approaching — with just 3 weeks to go, make sure you keep the date free! 📅 Friday 3rd April 🕚 From 11:00am 📍 Eaton Socon Cricket Club 🚗 Car parking is limited 💷 Cash preferred on the day #ESCC

EatonSoconcc's tweet image. Easter Family Fun Day 🐣

Our Easter Family Fun Day is fast approaching — with just 3 weeks to go, make sure you keep the date free!

📅 Friday 3rd April
🕚 From 11:00am
📍 Eaton Socon Cricket Club

🚗 Car parking is limited
💷 Cash preferred on the day

#ESCC

Corrida disputadíssima na ESCC! Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida! #ESCC #GoBravoSnow

BravoSnowBR's tweet image. Corrida disputadíssima na ESCC!

Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida!

#ESCC #GoBravoSnow
BravoSnowBR's tweet image. Corrida disputadíssima na ESCC!

Terminamos em P8, após um erro de calculo no combustível, mas satisfeitos de termos mostrado um bom ritmo na corrida!

#ESCC #GoBravoSnow

Excited to share our Ph2 PALADIN trial poster! #GI26 @ASCO @OncoAlert #Pembrolizumab #ESCC

DaisukeKotani's tweet image. Excited to share our Ph2 PALADIN trial poster! #GI26 

@ASCO @OncoAlert  #Pembrolizumab #ESCC

ASCO-GI 2026, abstr TPS471 🔷PALADIN: Ph2 of pembro + chemo with SCRT (25Gy/5fr) as induction tx for unresectable LA-ESCC 👉Please check out our ongoing trial exploring ICI + hypofractionated RT strategy! #GI26 @ASCO @OncoAlert



💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC 🎯mOS: 25.6 vs 12.3m | HR 0.49 🎯mPFS: 9.7 vs 6.9m | HR 0.56 🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m For LA ESCC, tislelizumab adds reason to the rationale. 🔍 #OncoAlert @OncoAlert

MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert
MarioBalsaMD's tweet image. 💥 RATIONALE-306 at #ESMOGI25: Tislelizumab + chemo improves OS vs placebo + chemo in LA #ESCC

🎯mOS: 25.6 vs 12.3m | HR 0.49
🎯mPFS: 9.7 vs 6.9m | HR 0.56
🎯ORR 61% vs 39% | DoR 22.1 vs 5.7m

For LA ESCC, tislelizumab adds reason to the rationale. 🔍
#OncoAlert @OncoAlert

🎙️Join us for the BinanceLiveAMA series with #ESCC 🕰️ Date: 19th Dec 2024, 8 PM UTC+8 🏆 Prize: $100 USD 🏠 Venue: binance.com/en/live/u/2747… 〽️Rules: 1️⃣ Follow @Cryptowhale1988 & @ESCC_io 2️⃣ Like & RT 3️⃣ Comment your Questions (Max 3) 4️⃣ Tag 3 Friends

CryptoWhale1988's tweet image. 🎙️Join us for the BinanceLiveAMA series with #ESCC

🕰️ Date: 19th Dec 2024, 8 PM UTC+8
🏆 Prize: $100 USD 
🏠 Venue: binance.com/en/live/u/2747…

〽️Rules:
1️⃣ Follow @Cryptowhale1988 & @ESCC_io
2️⃣ Like & RT
3️⃣ Comment your Questions (Max 3)
4️⃣ Tag 3 Friends

Consensus Molecular Subtypes of #ESCC ✅Key previous classifications ◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017) ◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023) ✅This study integrates 8 prior systems to establish 4 consensus subtypes ◾️ECMS1-MET (metabolic): Dysregulated

DaisukeKotani's tweet image. Consensus Molecular Subtypes of #ESCC
✅Key previous classifications
◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017)
◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023)

✅This study integrates 8 prior systems to establish 4 consensus subtypes
◾️ECMS1-MET (metabolic): Dysregulated
DaisukeKotani's tweet image. Consensus Molecular Subtypes of #ESCC
✅Key previous classifications
◾️TCGA: ESCC1, ESCC2, ESCC3 (Nature 2017)
◾️Multi-omics: NRFA, CCA, IM, IS (Cancer Cell 2023)

✅This study integrates 8 prior systems to establish 4 consensus subtypes
◾️ECMS1-MET (metabolic): Dysregulated

Excited to announce our strategic partnership with @ESCC_io! 🚀 #ESCC is a public blockchain based on #EOS and EOS EVM architecture, designed for stablecoin scenarios. Together, #Insctools and ESCC aim to drive innovation and redefine stablecoin applications.

InscTools_'s tweet image. Excited to announce our strategic partnership with @ESCC_io! 🚀 #ESCC is a public blockchain based on #EOS and EOS EVM architecture, designed for stablecoin scenarios. 

Together, #Insctools and ESCC aim to drive innovation and redefine stablecoin applications.

🎉🎉Excited to announce our partnership with @ESCC_io, #ESCC is a public blockchain base on #EOS & #EOS EVM architecture, support stablecoin scenarios, 🍻🍻 @Filecoin @FilFoundation Let`s build together !🎉🎉

filenova_org's tweet image. 🎉🎉Excited to announce our partnership with @ESCC_io,

#ESCC is a public blockchain base on #EOS & #EOS EVM architecture, support stablecoin scenarios,

🍻🍻 @Filecoin @FilFoundation 
Let`s build together !🎉🎉

#AtemNetwork welcomes a new partner @ESCC_io 🌊Eos Stable Coin Chain (#ESCC) is a public blockchain based on #EOS and #EOS EVM architecture, designed to support stablecoin scenarios!

atem_network's tweet image. #AtemNetwork welcomes a new partner @ESCC_io

🌊Eos Stable Coin Chain (#ESCC) is a public blockchain based on #EOS and #EOS EVM architecture, designed to support stablecoin scenarios!

🏀 #ESCC #GAMEDAY🏀 @ViatorGBB vs. Nazareth Academy 🏟️ Saint Viator HS 📍1213 E Oakton St, Arlington Hts 60004 📺 fan.hudl.com/usa/il/arlingt… #GoLions

ViatorGBB's tweet image. 🏀 #ESCC #GAMEDAY🏀

@ViatorGBB vs. Nazareth Academy

🏟️ Saint Viator HS
📍1213 E Oakton St, Arlington Hts 60004
📺 fan.hudl.com/usa/il/arlingt…

#GoLions

New hope for #ESCC patients. Tislelizumab + chemo improves median OS to 16.8 months vs. 9.6 months with placebo in PD-L1+ patients. A game-changer in 1st-line treatment. bit.ly/41Ftp8S #EsophagealCancer #MedTwitter #Immunotherapy

OncNewsCentral's tweet image. New hope for #ESCC patients. Tislelizumab + chemo improves median OS to 16.8 months vs. 9.6 months with placebo in PD-L1+ patients. A game-changer in 1st-line treatment. bit.ly/41Ftp8S #EsophagealCancer #MedTwitter #Immunotherapy

A new multi-center, diagnostic trial included patients with locally advanced esophageal squamous cell carcinoma (ESCC) who were treated with neoadjuvant chemoradiation and esophagectomy. Read more on how active surveillance can be used for #ESCC patients. ow.ly/cZmp50Ubizy

OncologyTimes's tweet image. A new multi-center, diagnostic trial included patients with locally advanced esophageal squamous cell carcinoma (ESCC) who were treated with neoadjuvant chemoradiation and esophagectomy. Read more on how active surveillance can be used for #ESCC patients. ow.ly/cZmp50Ubizy

Esophageal squamous cell carcinoma (#ESCC), while not common in the United States, is the most common form of esophageal cancer in Asia. A recent study by Zhigang Li, MD, PhD, considers active surveillance in treatment approaches. Read more: ow.ly/ZhBy50U6hqO

OncologyTimes's tweet image. Esophageal squamous cell carcinoma (#ESCC), while not common in the United States, is the most common form of esophageal cancer in Asia. A recent study by Zhigang Li, MD, PhD, considers active surveillance in treatment approaches. Read more: ow.ly/ZhBy50U6hqO

Complete the FAFSA today to get access to federal funding for school! Visit studentaid.gov to get started. Have questions? Visit escc.edu/financialaid! #FAFSA #ESCC

EnterpriseState's tweet image. Complete the FAFSA today to get access to federal funding for school! Visit studentaid.gov to get started.  
Have questions? Visit escc.edu/financialaid! #FAFSA #ESCC

Debate at #ESCC today on whether to #divest all #pensionfunds from unhealthy #fossilfuels. The debate was won by years of campaigning by @DivestEast. Lets hope for a positive decision by the councillors @MP_Divest @richardcasson

owstonlewis's tweet image. Debate at #ESCC today on whether to #divest all #pensionfunds from unhealthy #fossilfuels. The debate was won by years of campaigning by @DivestEast. Lets hope for a positive decision by the councillors @MP_Divest @richardcasson

📢 #KODO is glad to announce our partnership with @ESCC_io, for the best fiat on&off ramp service. #ESCC is a public blockchain based on #EOS and #EOS EVM architecture, designed to enhance stablecoin transactions. Together, we are redefining #crypto transactions. Let's create

KodoCrypto's tweet image. 📢 #KODO is glad to announce our partnership with @ESCC_io, for the best fiat on&off ramp service.

#ESCC is a public blockchain based on #EOS and #EOS EVM architecture, designed to enhance stablecoin transactions.

Together, we are redefining #crypto transactions. Let's create

🚧 ESCC Highways are out tonight removing flags painted on mini roundabouts in the Newhaven area. ❓ But how long until the next ones appear – and is this really money well spent by the council? #Newhaven #SussexNews #ESCC @SussexTW

SussexIncidents's tweet image. 🚧 ESCC Highways are out tonight removing flags painted on mini roundabouts in the Newhaven area.

❓ But how long until the next ones appear – and is this really money well spent by the council?

#Newhaven #SussexNews #ESCC

@SussexTW

We are happy to announce our partnership with @ESCC_io #ESCC – a cutting-edge public blockchain based on #EOS and #EOS EVM architecture, designed to enhance stablecoin transactions. ESCC combines the speed and scalability of EOS with the flexibility of Ethereum's smart

SocialGrowAI's tweet image. We are happy to announce our partnership with @ESCC_io 

#ESCC – a cutting-edge public blockchain based on #EOS and #EOS EVM architecture, designed to enhance stablecoin transactions. ESCC combines the speed and scalability of EOS with the flexibility of Ethereum's smart

#ESCC #GoLions Bella Gounaris 6 pts, 1 reb Ava Garcia 4 pts, 2 rebs, 2 assts, 1 stl, 1 blk Emily Walberg 4 pts, 2 rebs

ViatorGBB's tweet image. #ESCC #GoLions

Bella Gounaris 6 pts, 1 reb
Ava Garcia 4 pts, 2 rebs, 2 assts, 1 stl, 1 blk
Emily Walberg 4 pts, 2 rebs

Loading...

Something went wrong.


Something went wrong.